Matches in Nanopublications for { ?s ?p "[The 5-HT(3) receptor antagonists, via a central and / or peripheral action, have been shown to reduce secretion and motility in the gut and possess clinical utility in irritable bowel syndrome, and possibly other visceral pain disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_assertion description "[The 5-HT(3) receptor antagonists, via a central and / or peripheral action, have been shown to reduce secretion and motility in the gut and possess clinical utility in irritable bowel syndrome, and possibly other visceral pain disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP197411.RAvYLW7MHmeLesCmdvcBjEbMARf8vazLpc5l7WSAxoYrk130_provenance.
- NP471985.RAZ8XgSVtBTEcze6pzOBrvV4fY6fYUFO3XdSZK2nAMNDU130_assertion description "[The 5-HT(3) receptor antagonists, via a central and / or peripheral action, have been shown to reduce secretion and motility in the gut and possess clinical utility in irritable bowel syndrome, and possibly other visceral pain disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP471985.RAZ8XgSVtBTEcze6pzOBrvV4fY6fYUFO3XdSZK2nAMNDU130_provenance.
- NP431818.RANLqrdjdh4hiCe7kSZZ9FqmQRRCZ9vr6bsllFy3mS2is130_assertion description "[The 5-HT(3) receptor antagonists, via a central and / or peripheral action, have been shown to reduce secretion and motility in the gut and possess clinical utility in irritable bowel syndrome, and possibly other visceral pain disorders.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP431818.RANLqrdjdh4hiCe7kSZZ9FqmQRRCZ9vr6bsllFy3mS2is130_provenance.